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Summary
Peutz-Jeghers syndrome (PJS) is an autosomal domi-
nant disease with variable expression and incom-
plete penetrance, characterized by mucocutaneous pig-
mentation and hamartomatous polyposis. Patients with
PJS have increased frequency of gastrointestinal and ex-
traintestinal malignancies (ovaries, testes, and breast). In
order to map the locus (or loci) associated with PJS, we
performed a genomewide linkage analysis, using DNA
polymorphisms in six families (two from Spain, two
from India, one from the United States, and one from
Portugal) comprising a total of 93 individuals, including
39 affected and 48 unaffected individuals and 6 indi-
viduals with unknown status. During this study, local-
ization of a PJS gene to 19p13.3 (around marker
D19S886) had been reported elsewhere. For our fami-
lies, marker D19S886 yielded a maximum LOD score
of 4.74 at a recombination fraction (v) of .045; multi-
point linkage analysis resulted in a LOD score of 7.51
for the interval between D19S886 and 19pter. However,
markers on 19q13.4 also showed significant evidence
for linkage. For example, D19S880 resulted in a max-
imum LOD score of 3.8 at . Most of this positivev  .13
linkage was contributed by a single family, PJS07. These
results confirm the mapping of a common PJS locus on
19p13.3 but also suggest the existence, in a minority of
families, of a potential second PJS locus, on 19q13.4.
Positional cloning and characterization of the PJS mu-
tations will clarify the genetics of the syndrome and the
implication of the gene(s) in the predisposition to
neoplasias.
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Introduction
The identification of genes involved in the predisposition
to human neoplasias is of importance, since it provides
a better understanding of the pathogenesis of cancer and
contributes to the possibility of diagnosis, prognosis, and
therapeutic interventions. Monogenic hereditary syn-
dromes that predispose to cancers are of particular in-
terest, because they could provide the genomic mapping
position of the gene involved and, subsequently, the clon-
ing, characterization, and functional analysis of the af-
fected gene. Peutz-Jeghers syndrome (PJS) is a rare, au-
tosomal dominant disease with variable and incomplete
penetrance, characterized by gastrointestinal hamarto-
matous polyposis and mucocutaneous hypermelanotic
macules (melanin spots) on the lips, buccal mucosa, and
digits (Jeghers et al. 1949; Foley et al. 1988). Patients
with PJS demonstrate a high risk for gastrointestinal
cancers (small bowel and colon, pancreatic, and stom-
ach) (Giardiello et al. 1987) and cancers of other organs,
such as the ovaries, testes, uterine cervix, and breast
(Young et al. 1982; Lehur et al. 1984; Gilks et al. 1989;
Buck et al. 1992). In addition, benign ovarian tumors
may occur in female PJS patients (Young et al. 1995).
The hamartomatous polyps usually are considered to be
of low malignant potential, but many reports have doc-
umented adenomatous and carcinomatous changes aris-
ing from these hamartomas (Perzin and Bridge 1982;
Foley et al. 1988).
In order to map the locus (or loci) associated with
PJS, we collected DNA from members of six PJS families
(two from Spain, one from Portugal, one from Utah,
and two from India), including 39 affected and 48 un-
affected individuals and 6 individuals with an unknown
diagnostic status. While performing a genomewide geno-
typing, using short-sequence-repeat (SSR) polymorphic
markers, Hemminki et al. (1997) reported localization
of a PJS gene to chromosome 19p13.3. Their highest
two-point LOD score was 5.40 at a recombination
fraction (v) of .00 for polymorphic marker D19S886.
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Figure 1 Pedigrees of the PJS families. “*DNA” indicates individuals for whom genotypes have been determined.
Furthermore, comparative genomic hybridization, com-
bined with studies of loss of heterozygosity (LOH), pro-
vided additional evidence for the involvement of the
19p13.3 genomic region, in PJS (Hemminki et al. 1997).
In this article, we confirm linkage of a PJS locus, in the
families we studied, to chromosome 19p13.3, since
marker D19S886 yielded a maximum two-point LOD
score of 4.74 at . The multipoint-analysis LODv  .04
score was 7.51 for the interval between D19S886 and
19pter. Furthermore, during the genomewide genotyp-
ing, we observed another genomic region with evidence
suggestive of linkage, around marker D19S880 on chro-
mosome 19q13.4. For this marker, the maximum LOD
score, determined by use of all the families, was 3.80 at
. Most of this positive linkage was contributedv  .13
by a single family, PJS07. This family alone gave a LOD
score of 3.52 at for markers D19S877 andv  .00
D19S891. Multipoint analysis using genotypes from
family PJS07 yielded a LOD score of 3.9 for the interval
between D19S180 and D19S254 on 19q13.4. These re-
sults confirm the existence of a PJS locus on 19p13.3
but also raise the possibility of a second locus, on chro-
mosome 19q13.4.
Subjects and Methods
Families with PJS
We identified six families with affected individuals
who fulfilled the criteria for the diagnosis of PJS (OMIM
175200 [http://www3.ncbi.nlm.nih.gov/omim/]), and
we collected blood samples from their affected and un-
affected members. Each of these families contained more
than one individual with PJS. The ascertainment of the
families was from a literature search or through personal
contacts with gastroenterologists. Two of the families
were from Spain (PJS01 and PJS03), one was from Por-
tugal (PJS06), one was from the United States (PJS05),
and two were from India (PJS07 and PJS08) (fig. 1). We
classified as affecteds those individuals with mucocuta-
neous hypermelanotic macules and/or hamartomatous
polyps. There were 39 affecteds in our sample. The di-
agnostic status of six individuals was considered to be
unknown, either because invasive diagnostic procedures
were not performed or because they were too young to
demonstrate the diagnostic signs. A total of 48 individ-
uals were classified as unaffected; however, in view of
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Figure 2 Ideogram of chromosome 19, showing locations of the
markers analyzed in this study. The order of these markers was ob-
tained from the Ge´ne´thon linkage map (http://www.genethon.fr/), the
CHLC linkage map (http://www.chlc.org/), and the Third International
Workshop on Chromosome 19 Mapping (Mohrenweiser et al. 1996).
the reduced penetrance of the disease, it is not unlikely
that some of these individuals are carriers of a mutant
PJS gene. All participants were enrolled in the study in
accordance with approved clinical protocols from the
University of Geneva and the local institutions, and they
were asked to provide blood after signing informed
consents.
DNA Polymorphism and Linkage Analysis
Genomic DNA was purified from peripheral blood
lymphocytes, in accordance with the standard
SDS–proteinase K and phenol/chloroform extraction
method. DNA polymorphisms were analyzed by PCR
amplification of SSRs. These markers were selected from
the Ge´ne´thon and Cooperative Human Linkage Center
(CHLC) collections (NIH/CEPH Collaborative Mapping
Group 1992; Buetow et al. 1994; Gyapay et al. 1994;
Murray et al. 1994; Dib et al. 1996). One oligonucleo-
tide primer of each marker was labeled with 5 mCi of
g-[32P]ATP with T4 polynucleotide kinase. PCR was per-
formed with MJ Research PTC-100 and Biometra UNO
I thermocyclers, to amplify 90 ng of genomic DNA in
a total volume of 15 ml per reaction, containing 0.4 pmol
of labeled forward primer, 2.6 pmol of unlabeled reverse
primer, 1.3 mM of each dNTP, and 0.25 U of Taq poly-
merase. PCR products were separated by electrophoresis
on a 6% denaturing urea/polyacrylamide gel (Blouin et
al. 1995). Genotypes were scored independently by two
different investigators, after autoradiography. Family in-
formation and marker genotypes were stored in the ped-
igree computer program Cyrillic. Linkage analysis was
performed by use of the ILINK, MLINK, and LINKMAP
programs of LINKAGE version 5.2 (Lathrop et al. 1984)
and the FASTLINK version 3.0 (Cottingham et al. 1993)
and VITESSE (O’Connell and Weeks 1995) software
packages. Multipoint linkage analysis was performed
with the help of the computer facility of the U.K. Human
Genome Mapping Project Resource Centre (http://
www.hgmp.mrc.ac.uk/). Maximum LOD and location
scores were calculated for each marker locus by assum-
ing an autosomal dominant mode of inheritance with
90% penetrance. The gene frequency of PJS was esti-
mated as 1/10,000. For all polymorphic markers, the
allele frequencies were considered to be equal. For the
multipoint linkage analysis, the intermarker genetic dis-
tances were based on the published Ge´ne´thon/CHLC
maps and were as reported from the Third International
Workshop on Chromosome 19 Mapping (Mohrenweiser
et al. 1996).
Results
The alleles of a total of 168 polymorphic markers
from throughout the human genome were genotyped for
the members of the six PJS families collected (a list of
these markers can be supplied via E-mail; contact
H.M. at Hamid.Mehenni@medecine.unige.ch). Approx-
imately 60% of the genome was analyzed for linkage,
by use of these markers. A region on chromosome
19q13.4 that showed pairwise positive LOD scores 13
(see below) was identified. During the course of this anal-
ysis, Hemminki et al. (1997) reported linkage of a PJS
locus to markers on chromosome 19p13.3; no hetero-
geneity was found in the 12 families (containing 34 af-
fected individuals) that they reported. We therefore fo-
cused on markers on the entire chromosome 19 (fig. 2).
More than 22 markers have been analyzed on this chro-
mosome, and the results of two-point linkage analysis
are shown in table 1. A maximum two-point LOD score
of 4.74 was obtained for D19S886 on 19p13.3 at v 
, by use of 90% penetrance. Analysis with the.045
HOMOG program showed no evidence of heterogeneity
( ). In the study by Hemminki et al. (1997), aa  1.0
maximum LOD score also was detected with locus
D19S886. A likely recombinant between D19S886 and
the PJS phenotype was detected in family PJS06 (male
individual IV-27). Additional markers in the 19p13.3
region also yielded positive LOD scores 13. Multipoint
linkage analysis, shown in figure 3, resulted in a max-
imum LOD score of 7.51 for the interval between
D19S886 and 19pter. The locus order and genetic dis-
tances between the loci used in this linkage analysis are
D19S886–0.053 cM–D19S565–0.083 cM–D19S894
(Ge´ne´thon map; Dib et al. 1996). The use of different
estimates of penetrance and disease-allele frequency did
not significantly affect the LOD score. Inspection of hap-
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Table 1
Results of Pairwise Two-Point Linkage Analysis between the PJS Phenotype and Selected Markers Covering the Entire Chromosome 19, at
Various v’s, for the PJS Families
MARKER
AND FAMILY
LOD SCORE AT v 
Zmax vmax.00 .01 .05 .10 .20 .30 .40
D19S886: 1.51 4.39 4.74 4.50 3.48 2.18 .89 4.74 .045
PJS01 2.12 2.08 1.92 1.70 1.25 .77 .29
PJS08 .03 .05 .10 .13 .12 .07 .02
PJS07 .65 .66 .67 .65 .53 .36 .17
PJS03 .57 .55 .48 .40 .25 .12 .03
PJS06 2.73 .19 .76 .88 .78 .51 .21
PJS05 .87 .86 .81 .73 .55 .35 .16
D19S878: 11.75 .84 1.72 2.48 2.45 1.68 .68 2.61 .142
PJS01 5.67 .21 .95 1.25 1.21 .86 .39
PJS08 1.15 1.07 .82 .58 .27 .10 .02
PJS07 2.61 .32 .86 .95 .81 .52 .18
PJS03 .78 .76 .68 .58 .38 .20 .06
PJS06 3.34 .88 .20 .03 .14 .10 .05
PJS05 .33 .32 .31 .28 .20 .11 .03
D19S565: 5.75 2.08 3.96 4.36 3.79 2.5 1.04 4.36 .1
PJS01 1.60 1.05 1.55 1.58 1.33 .9 .39
PJS08 1.50 1.40 1.01 .67 .3 .12 .03
PJS07 2.54 2.49 2.29 2.02 1.45 .86 .32
PJS03 .78 .76 .68 .58 .38 .20 .06
PJS06 2.44 .08 .70 .86 .78 .51 .20
PJS05 3.54 .90 .24 .01 .14 .15 .09
D19S247: 7.17 .82 2.61 3.09 2.83 1.91 .79 3.12 .122
PJS01 1.60 1.35 1.82 1.84 1.53 1.05 .47
PJS08 .03 .03 .03 .02 .01 .01 .00
PJS07 2.47 2.42 2.21 1.94 1.38 .78 .24
PJS03 .57 .55 .48 .4 .25 .12 .03
PJS06 5.12 2.65 1.69 1.09 .42 .10 .02
PJS05 3.52 .88 .24 .02 .08 .06 .02
D19S894: 5.92 .98 3.38 3.95 3.56 2.41 1.01 3.97 .118
PJS01 2.16 .35 .83 1.14 1.13 .82 .38
PJS08 .03 .03 .03 .02 .01 .01 .00
PJS07 2.26 2.25 2.18 2.03 1.59 1.03 .41
PJS03 .78 .76 .68 .58 .38 .20 .06
PJS06 3.29 .81 .08 .21 .37 .30 .15
PJS05 3.55 .91 .26 .04 .07 .06 .02
D19S1034: 13.52 3.96 .16 1.14 1.67 1.27 .61 1.67 .188
PJS01 3.64 2.10 .71 .17 .21 .25 .16
PJS08 4.89 .68 .08 .10 .15 .09 .02
PJS07 2.63 .31 .92 1.07 .96 .66 .32
PJS03 .78 .76 .68 .58 .38 .20 .06
PJS06 3.41 2.52 1.26 .73 .29 .13 .06
PJS05 .27 .28 .29 .29 .26 .20 .11
D19S413 20.02 6.22 1.88 .11 1.06 1.06 .55 1.15 .246
D19S586 16.68 1.84 1.27 2.19 2.35 1.74 .84 2.42 .158
D19S714 26.62 10.81 4.72 2.16 .15 .41 .32 .43 .328
D19S433 12.83 4.97 1.8 .36 .64 .73 .45 .75 .265
D19S178 27.92 11.54 5.46 2.78 .57 .16 .26 .27 .372
D19S246 27.59 13.2 6.92 4.00 1.32 .22 .15 .15 .42
D19S601 9.57 3.44 .44 .76 1.43 1.19 .59 1.43 .21
D19S589 4.03 1.19 .03 .68 1.08 .93 .52 1.08 .22
D19S180 7.09 3.78 .88 .40 1.21 1.15 .69 1.25 .235
(continued)
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Table 1 (continued)
MARKER
AND FAMILY
LOD SCORE AT v 
Zmax vmax.00 .01 .05 .10 .20 .30 .40
D19S926: 15.96 5.54 1.25 .44 1.48 1.34 .69 1.52 .229
PJS01 3.31 .76 .10 .48 .70 .60 .32
PJS08 .08 .10 .14 .15 .12 .06 .01
PJS07 2.96 2.91 2.68 2.39 1.77 1.11 .47
PJS03 4.77 2.80 1.44 .89 .39 .15 .04
PJS06 2.91 1.76 .98 .60 .25 .09 .03
PJS05 8.01 3.22 1.75 1.09 .47 .18 .04
D19S880: 10.31 .96 3.07 3.72 3.56 2.55 1.17 3.80 .13
PJS01 2.98 .38 .38 .67 .79 .62 .32
PJS08 .36 .31 .16 .04 .06 .06 .02
PJS07 4.41 1.86 2.31 2.27 1.85 1.22 .50
PJS03 .78 .76 .68 .58 .38 .20 .06
PJS06 3.13 .77 .01 .34 .54 .47 .27
PJS05 .21 .20 .15 .11 .05 .02 .00
D19S877: 15.76 4.71 .48 1.09 1.88 1.52 .73 1.88 .20
PJS01 8.13 3.06 1.46 .73 .10 .10 .10
PJS08 .08 .10 .14 .15 .13 .07 .02
PJS07 3.52 3.46 3.20 2.87 2.15 1.38 .61
PJS03 4.77 2.80 1.44 .89 .39 .15 .04
PJS06 2.76 1.42 .62 .27 .01 .04 .02
PJS05 3.71 1.00 .30 .04 .10 .08 .02
D19S891: 6.42 .77 1.37 2.12 2.23 1.62 .75 2.31 .156
PJS01 3.79 1.24 .36 .05 .34 .33 .18
PJS08 .03 .03 .03 .02 .01 .01 .00
PJS07 3.52 3.46 3.20 2.87 2.15 1.38 .61
PJS03 .78 .76 .68 .58 .38 .20 .06
PJS06 3.2 2.29 1.43 .97 .51 .25 .10
PJS05 3.77 1.5 .75 .43 .15 .05 .01
D19S887: 25.01 9.74 4.39 2.03 .12 .37 .29 .38 .325
PJS01 4.54 3.59 1.86 .98 .15 .16 .19
PJS08 9.30 2.18 1.32 .88 .41 .17 .04
PJS07 1.11 1.09 1.00 .88 .65 .41 .19
PJS03 4.83 2.8 1.44 .89 .39 .15 .04
PJS06 .64 .67 .74 .73 .55 .26 .02
PJS05 8.09 2.93 1.51 .91 .37 .14 .03
D19S210: 20.55 8.22 3.13 .94 .75 1.05 .62 1.06 .283
PJS01 3.97 3.17 1.55 .75 .04 .21 .20
PJS08 .08 .10 .16 .19 .17 .10 .03
PJS07 3.76 2.46 2.86 2.78 2.26 1.52 .66
PJS03 4.83 2.8 1.44 .89 .39 .15 .04
PJS06 3.6 2.67 1.81 1.33 .77 .42 .18
PJS05 4.47 2.14 1.35 .95 .48 .20 .05
D19S254: 11.24 .34 1.8 2.52 2.53 1.81 .87 2.66 .146
PJS01 .93 .94 .97 .94 .77 .52 .26
PJS08 1.24 1.16 .88 .62 .28 .11 .02
PJS07 4.30 1.56 2.02 2.00 1.63 1.08 .51
PJS03 .22 .20 .14 .08 .03 .01 .00
PJS06 1.84 .19 .41 .56 .53 .33 .13
PJS05 4.57 1.30 .58 .29 .07 .01 .01
NOTE.—LOD scores determined by use of the MLINK and ILINK programs. The order of markers is from 19pter to 19qter, as determined
in the CHLC linkage map, version 4 (http://www.chlc.org/), the Ge´ne´thon linkage map (http://www.genethon.fr/), and the report from the Third
International Workshop on Chromosome 19 Mapping (Mohrenweiser et al. 1996). For each marker, the first line of data indicates the results
determined by use of genotypes from all six families; the LOD scores for each family also are shown. For some markers only the LOD scores
for all six families are shown.
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Figure 3 Multipoint linkage analysis between the PJS pheno-
type and three selected chromosome 19p13.3 markers
(D19S886–D19S565–D19S894), determined by use of genotypes from
all the families. Marker D19S886 was set at map position zero. The
map distances were calculated by use of the Haldane mapping
function.
Figure 4 Multipoint-linkage-analysis curve for markers on chro-
mosome 19q13.4 (D19S180–D19S877–D19S891–D19S254), deter-
mined by use of genotypes from family PJS07. Marker D19S180 was
set at map position zero. The map distances were calculated by use
of the Haldane mapping function.
lotypes for polymorphic markers in 19p13.3 did not
reveal any association between a particular haplotype
and the PJS locus. This is compatible with the inde-
pendent occurrence of mutations at the PJS locus in dif-
ferent populations and families.
As stated earlier, a genomic region on chromosome
19q13.4 that is unlinked to 19p13.3 also yielded sig-
nificant LOD scores. Marker D19S880 resulted in a
maximum two-point LOD score of 3.80 at .v  .13
Most of the evidence for linkage with this marker was
obtained from Indian family PJS07, which alone yielded
a maximum LOD score of 3.52 at , for neigh-v  .00
boring markers D19S877 and D19S891. Analysis with
the HOMOG program showed evidence for heteroge-
neity ( and .36 for markers D19S877 anda  .21
D19S891, respectively). Multipoint linkage analysis us-
ing genotypes of family PJS07 resulted in a maximum
LOD score of 3.9 for the interval between D19S180 and
D19S254 (fig. 4).
Discussion
We have used linkage analysis to map the locus (loci)
for autosomal dominant PJS. Using DNA from members
of six families, with 39 affected individuals, we were
able to confirm linkage to marker D19S886 on 19p13.3,
recently reported by Hemminki et al. (1997). Unlike this
latter study, in which no crossover was observed with
marker D19S886, the linkage analysis of the families
that we studied revealed that at least one of these families
(PJS06) showed a recombination with this marker. How-
ever, it is unknown whether family PJS06 is linked to
the 19p13.3 chromosomal region. In addition, the ap-
parent recombination occurred in an unaffected individ-
ual who may represent an example of incomplete pen-
etrance. Multipoint linkage analysis that included the
genotyping data from all the families studied indicated
that the PJS locus maps distal to D19S886. However, it
is possible that the locus for family PJS06 maps else-
where in the genome, and, therefore, the results from
the multipoint linkage analysis may be misleading. A
project to develop the physical map of chromosome 19,
comprising cosmids and other cloning vectors, has been
nearly completed by the Lawrence Livermore National
Laboratory (LLNL), and a considerable number of genes
already have been mapped to 19p13.3 (see the LLNL
gene ideogram for human chromosome 19 [http://www-
bio.llnl.gov/genome/html/geneideogram.html]). Some
of these genes are candidates for the PJS phenotype.
Clearly, more families and more polymorphic markers
distal to D19S886 need to be studied, since this is the
most distal 19pter marker available to narrow the crit-
ical region. It is unlikely that linkage disequilibrium will
help in further localization of the PJS region on 19p13.3,
because the disorder is dominant and because new mu-
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tations are more likely to occur in the most common
haplotypes. On the other hand, as suggested by Hem-
minki et al. (1997), studies of LOH in PJS polyps or
tumors may better demarcate the borders of the critical
region that harbors the mutated gene.
Interestingly, one family from India (PJS07) showed
high LOD scores with polymorphic markers on 19q13.4.
For example, for PJS07, the maximum LOD score for
markers D19S877 and D19S891 was 3.52 at v  .00
(for D19S880, the maximum LOD score determined by
use of genotypes from all the families was 3.80 at v 
). The same family, PJS07, was not very informative.11
for the most 19p telomeric markers but yielded
maximum LOD scores of 2.54 and 2.26 for markers
D19S565 and D19S894, respectively, at . Mul-v  .00
tipoint linkage analysis with markers D19S886–
D19S565–D19S894 on 19p13.3, using genotypes from
only family PJS07, resulted in a maximum LOD score
of 3.21 for the intervals on either side of marker
D19S565. Since the 19p13.3 markers are unlinked to
those at 19q13.4, it is possible that the considerably high
LOD score for 19q13.4 in family PJS07 is due to chance
only. Alternatively, it is possible that there is a second
locus for PJS, on 19q13.4. Mutations in this second locus
may result in PJS in a subset of PJS families. Further-
more, the gene products of these two loci may interact,
and the development of a PJS phenotype may be the
result of the interaction of mutant proteins encoded by
both loci. An example of so-called digenic inheritance
already has been well documented in one form of au-
tosomal dominant retinitis pigmentosa (Kajiwara et al.
1994). It would be of interest to determine the genotypes
of markers on 19q13.4 in the families described by Hem-
minki et al. (1997), in order to study the contribution
of a potential locus on 19q13.4 in these families. Evi-
dence of LOH on chromosome 19q13.4 was not ob-
served in the data reported by Hemminki et al. (1997).
Positional cloning experiments and mutation analyses of
candidate genes (e.g., see the National Center for Bio-
technology Information [http://www.ncbi.nlm.nih.gov/
SCIENCE96/]) are now in progress for the cloning and
characterization of the PJS gene on 19p13.3.
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